2-fluoro-5-(trifluoroMethyl)pyriMidine

2-Fluoro-5-trifluoromethylpyrimidine is an important intermediate in pharmaceutical synthesis, used to synthesize fused-ring dihydrofurans. These dihydrofurans can act as modulators of the G protein-coupled receptor GPR119, used to treat diabetes, obesity, and dyslipidemia. Furthermore, 2-fluoro-5-trifluoromethylpyrimidine can also serve as an intermediate in the synthesis of drugs for treating Alzheimer's disease and schizophrenia.